View Clinical Trial (Medical Research Study)

The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage - NCT00991198-27262(Clinical Trial 368448)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  High Point
State:  
NC
Zip Code: 27262
Conditions: Rosacea - Acne Vulgaris - Atopic Dermatitis - Seborrheic Dermatitis
Purpose: This study is an evaluation of the role of topical dissolved oxygen to lessen visible signs of photodamage using a select regimen of topical dissolved oxygen containing cosmeceutical products. Evaluation of the overall skin tolerability of topical dissolved oxygen (safety) utilizing the regimen of products.
Study summary:
Criteria: Inclusion Criteria: - Subjects must be female, 25-60 years old in good general health; - Subjects must be Fitzpatrick Types I, II, III, IV, V - Subjects must be willing to forgo the use of facial cosmetics (e.g. facial moisturizers,creams, foundations, blush, etc.) during the course of the study. - Subjects may ONLY use facial regimen of products provided by sponsor(lipstick, lip gloss, and eye mascara permitted). Exclusion Criteria: - Known sensitivity to any of the test material ingredients. - Routine high dosage use of anti-inflammatory medications (aspirin, ibuprofen, corticosteroids), immunosuppressive drugs or antihistamine medications (steroid nose drops and/or eye drops are permitted) (one-8lmg or 325mg aspirin okay) (birth control is okay but needs to be reported). - Use of topical OTC/Rx drugs or other cosmetics at the test sites. - Immunological disorders such as HIV positive and systemic lupus erythematosus (interview only) - Participation in any clinical study within the last four weeks. - Pregnant or lactating women (interview only). - Damaged skin in or around test sites (including sunburn, uneven skin tones, tattoos, scars or other disfiguration of the test site).
Study is available at: Dermatology Consultants Inc
High Point, NC 27262
United States

Primary Contact:
Zoe Draelos, MD
Phone: 336-841-2040

Secondary Contact:
Zoe D Draelos, MD
Phone: 336-841-2040
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.